NASDAQ · PFSAHealthcareSurgical Instruments

Profusa financials

$2.27+34.32%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ2 '26
Jun 30
Q1 '26
Mar 31
Q4 '25
Dec 31
Q3 '25
Sep 30
Revenue$0.00$0.00$0.00$0.00
Gross profit$0.00$0.00$0.00$0.00
Gross margin————
Operating income-$2.5M-$4.0M-$3.6M-$21.7M
Net income-$8.8M-$3.5M-$8.6M-$22.2M
Net margin————
Diluted EPS$-151.80$-2.05—$-0.70
EBITDA-$2.5M-$4.0M-$3.6M-$21.7M
Operating cash flow-$2.6M-$2.6M-$5.1M-$10.6M
Free cash flow-$2.7M-$2.6M-$5.1M-$10.6M
Diluted shares0.1M1.7M—31.7M

Balance sheet

Period endJun 30Mar 31Dec 31Sep 30
Cash & equivalents$719.0K$375.0K$1.8M$3.0M
Short-term investments$0.00$0.00$0.00$0.00
Total debt$8.9M$7.7M$10.3M$6.7M
Total assets$1.0M$862.0K$3.8M$4.3M
Total liabilities$28.2M$29.1M$30.4M$38.2M
Shareholders' equity-$27.1M-$28.2M-$26.7M-$34.0M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology